Obesity Paradox Clinical Trial
Official title:
Obesity Paradox in Non Valvular Atrial Fibrillation
NCT number | NCT03904329 |
Other study ID # | Assuit35 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | October 1, 2020 |
Est. completion date | October 1, 2023 |
Obesity paradox In patient with non valvular atrial fibrillation
Status | Recruiting |
Enrollment | 1 |
Est. completion date | October 1, 2023 |
Est. primary completion date | August 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - patients presented with non valvular AF - patients on oral anticoagulant Exclusion Criteria: - valvular AF - Mental illness - History of cerebrovascular stroke - history of bleeding tendency - history of Chronic renal failure |
Country | Name | City | State |
---|---|---|---|
Egypt | Kristen amir | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Correlation between obesity and outcomes in non valvular atrial fibrillation | To study effect of obesity in outcomes of non valvular atrial fibrillation regarding the effect of obesity in the outcome of anticoagulants | Sixth months |